discovered that the expression of AMPAR and its deubiquitinating enzyme, Ubiquitin-specific peptidase 46 (USP46), significantly decreased in Aβ-treated neurons and human brain tissues of AD patients. Here, USP46 is linked to Alzheimer disease.